Biocon
Biocon's Overview
Biocon Limited is an Indian biopharmaceutical company headquartered in Bengaluru, India, founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) and complex biologics, including biosimilar insulins and monoclonal antibodies. Biocon's core therapeutic areas include diabetes, oncology, immunology, and other chronic diseases. It is committed to enhancing affordable access to life-saving therapies for patients worldwide and has a significant presence in over 120 countries, including developed markets like the United States and Europe.
Where is Biocon's Headquarters?
HQ Function
Serves as the central hub for corporate operations, strategic decision-making, and extensive research and development activities. Key manufacturing facilities are also co-located or situated nearby.
Notable Features:
Biocon Park is a sprawling, state-of-the-art campus featuring advanced R&D laboratories, cGMP-compliant manufacturing units, and modern corporate offices. The campus design often emphasizes sustainability and an environment conducive to innovation.
Work Culture:
Biocon fosters a work culture centered on innovation, scientific rigor, collaboration, and an entrepreneurial mindset. Employees often describe it as a dynamic and challenging environment with significant opportunities for learning and contributing to global healthcare solutions.
HQ Significance:
The Bengaluru headquarters is pivotal as it's the origin of Biocon and a testament to India's capabilities in the global biopharmaceutical sector. It symbolizes the company's journey from a small enzyme manufacturer to a global biopharma enterprise.
Values Reflected in HQ: The headquarters embodies Biocon's core values: commitment to innovation (through advanced R&D infrastructure), quality and compliance (world-class manufacturing standards), integrity, and a patient-centric approach to making healthcare affordable.
Location:
Biocon has established a robust global presence, with its products reaching patients in over 120 countries. The company's international operations are supported by a network of advanced R&D centers, world-class manufacturing facilities in India and Malaysia, and commercial offices in key markets including the USA, Europe, UAE, and various emerging economies. This expansive network allows Biocon to manage the full lifecycle of its products globally, from research and development through manufacturing and commercialization, reinforcing its mission of providing affordable and innovative healthcare solutions worldwide.
Street Address:
20th KM, Hosur Road, Electronic City
City:
Bengaluru
State/Province:
Karnataka
Country:
India
Biocon's Global Presence
Johor Bahru, Johor, Malaysia
Address: No. 1, Jalan Bioteknologi 1, Kawasan Perindustrian SiLC, 79200 Iskandar Puteri, Johor Darul Takzim, Malaysia
Serves as a strategic global manufacturing hub for biosimilars, leveraging Malaysia's pharmaceutical infrastructure and enabling supply to various international markets.
Iselin, New Jersey, USA
Address: 186 Wood Avenue South, Suite 306, Iselin, NJ 08830, USA (Representative office for Biocon Pharma Inc.)
Manages and expands Biocon's pharmaceutical footprint in the United States and Canada, focusing on market access and commercialization of its diverse product portfolio.
Dubai, UAE
Address: Biocon FZ LLC, Dubai Science Park, North Tower, Office No: 601, P.O Box: 500707, Dubai, UAE
Serves as a strategic hub to tap into the growing pharmaceutical market in the MENA region, addressing regional healthcare needs with Biocon's range of affordable therapies.
Buying Intent Signals for Biocon
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Biocon
As of April 2025, Biocon' leadership includes:
Investors of Biocon
Biocon has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Biocon has witnessed key leadership appointments over the past year to strengthen its strategic direction. This includes the appointment of a new Group CEO and a new CEO & MD for Biocon Limited, aiming to drive the company's next phase of growth and operational excellence.
Departures
New Appointments:
Technology (Tech Stack) used by Biocon
Discover the tools Biocon uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Biocon Email Formats and Examples
Biocon generally follows standard corporate email address patterns. The most common formats utilize a combination of the employee's first name and last name, or an initial followed by the last name, combined with the '@biocon.com' domain.
[first].[last]@biocon.com or [f][last]@biocon.com
Format
kiran.mazumdar@biocon.com
Example
85%
Success rate
News and media
Moneycontrol • May 16, 2024
Biocon Q4 FY24 Net Profit Declines 57% to Rs 135.5 Crore, Revenue Up 4%
Biocon reported a consolidated net profit of Rs 135.5 crore for the fourth quarter of FY24, a 57% year-on-year decrease, primarily due to exceptional items and increased R&D spending. However, revenue from operations saw a 3.8% rise to Rs 3,917 crore, with the biosimilars segment being a key growth driver....more
Biocon Press Release / Business Standard • February 29, 2024
USFDA Accepts Biocon Biologics' BLA for Review of Proposed Biosimilar Nivolumab
The U.S. Food and Drug Administration (USFDA) accepted for review Biocon Biologics' Biologics License Application (BLA) for Bmab 1200, a proposed biosimilar to Opdivo (Nivolumab). This is a significant regulatory milestone towards potentially offering a more affordable advanced cancer therapy in the US market....more
Biocon Press Release / The Economic Times • September 5, 2023
Biocon Biologics Completes Integration of Viatris' Biosimilar Business in North America
Biocon Biologics announced the successful completion of the integration of Viatris' acquired biosimilar business in North America, ahead of schedule. This strategic move significantly strengthens Biocon Biologics' commercial presence and provides direct market access in this key region....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Biocon, are just a search away.